Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients

about

Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients

Item

http://www.wikidata.org/entity/Q39999470

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Decreased circulating and neut ...... cardiac transplant recipients

@en

Decreased circulating and neut ...... cardiac transplant recipients.

@nl

type

Item

label

Decreased circulating and neut ...... cardiac transplant recipients

@en

Decreased circulating and neut ...... cardiac transplant recipients.

@nl

prefLabel

Decreased circulating and neut ...... cardiac transplant recipients

@en

Decreased circulating and neut ...... cardiac transplant recipients.

@nl

P1476

Decreased circulating and neut ...... cardiac transplant recipients

@en

P2093

Anique Ducharme

http://www.w3.org/2001/XMLSchema#string

Damien Vitiello

http://www.w3.org/2001/XMLSchema#string

Diana Chaar

http://www.w3.org/2001/XMLSchema#string

Guy B Pelletier

http://www.w3.org/2001/XMLSchema#string

Mark Liszkowski

http://www.w3.org/2001/XMLSchema#string

Martin G Sirois

http://www.w3.org/2001/XMLSchema#string

Michel Carrier

http://www.w3.org/2001/XMLSchema#string

Michel White

http://www.w3.org/2001/XMLSchema#string

Normand Racine

http://www.w3.org/2001/XMLSchema#string

Paul-Eduard Neagoe

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1

The balance between IL-1 and IL-1Ra in disease

IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

The experimental treatment of corneal graft rejection with the interleukin-1 receptor antagonist (IL-1ra) gene

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

Mammalian target of rapamycin and Rictor control neutrophil chemotaxis by regulating Rac/Cdc42 activity and the actin cytoskeleton

Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients.

Vascular endothelial growth factors and vascular permeability

P2888

s13221-015-0029-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13221-015-0029-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273656447

http://www.w3.org/2001/XMLSchema#string

P6179

1011949553

http://www.w3.org/2001/XMLSchema#string

P698

25922663

http://www.w3.org/2001/XMLSchema#string

P932

4411699

http://www.w3.org/2001/XMLSchema#string